Literature DB >> 7684238

Specific expression of tenascin in human colonic neoplasms.

T Sakai1, H Kawakatsu, N Hirota, T Yokoyama, T Sakakura, M Saito.   

Abstract

Tenascin, a novel six-armed extracellular matrix glycoprotein, was immunohistochemically examined in the human normal adult colon, and colonic neoplasms such as tubular adenomas, primary and metastatic adenocarcinomas. In contrast to previous reports, tenascin was hardly detectable in the normal adult colons, being predominantly localised in the fibrous stroma surrounding the glandular epithelia of the neoplastic lesions. The neoplastic cells themselves were totally negative for tenascin expression. Both the tubular adenoma tissues and the superficial layer of well-differentiated adenocarcinomas in general were intensely reactive to tenascin antibody, and the staining intensity increased as the adenoma became more atypical in cases of tubular adenomas. By pretreatment of the paraffin-embedded tissue sections with pepsin, the distribution of tenascin was often intensified considerably and distinct localisation was more clearly demonstrated in the colonic tumour tissues. Tenascin was also biochemically purified from human invasive colonic carcinomas, and this cancerous tissue tenascin was compared with that extracted from a human umbilical cord fibroblast cell line in terms of molecular heterogeneity. Two major isoforms of the purified tenascin from colonic cancer tissues were found to have relative molecular masses of 250 kD and 190 kD, which were almost identical to those of human foetal fibroblast tenascin glycoproteins. In addition, several lower molecular weight isoforms were frequently detectable in the cancerous tissues, which might represent immuno-reactive tenascin isoforms proteolytically digested in human colonic carcinomas in vivo.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7684238      PMCID: PMC1968444          DOI: 10.1038/bjc.1993.194

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  25 in total

Review 1.  Tumor invasion and metastases--role of the extracellular matrix: Rhoads Memorial Award lecture.

Authors:  L A Liotta
Journal:  Cancer Res       Date:  1986-01       Impact factor: 12.701

2.  Tenascin: an extracellular matrix protein involved in tissue interactions during fetal development and oncogenesis.

Authors:  R Chiquet-Ehrismann; E J Mackie; C A Pearson; T Sakakura
Journal:  Cell       Date:  1986-10-10       Impact factor: 41.582

3.  Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications.

Authors:  H Towbin; T Staehelin; J Gordon
Journal:  Proc Natl Acad Sci U S A       Date:  1979-09       Impact factor: 11.205

4.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

5.  Immunocytochemical enhancement of basement membrane antigens by pepsin: applications in diagnostic pathology.

Authors:  S H Barsky; N C Rao; C Restrepo; L A Liotta
Journal:  Am J Clin Pathol       Date:  1984-08       Impact factor: 2.493

6.  Murine tenascin: cDNA cloning, structure and temporal expression of isoforms.

Authors:  Y Saga; T Tsukamoto; N Jing; M Kusakabe; T Sakakura
Journal:  Gene       Date:  1991-08-15       Impact factor: 3.688

7.  Comparative analysis of the expression of the extracellular matrix protein tenascin in normal human fetal, adult and tumor tissues.

Authors:  P G Natali; M R Nicotra; A Bigotti; C Botti; P Castellani; A M Risso; L Zardi
Journal:  Int J Cancer       Date:  1991-04-01       Impact factor: 7.396

8.  Human tenascin: primary structure, pre-mRNA splicing patterns and localization of the epitopes recognized by two monoclonal antibodies.

Authors:  A Siri; B Carnemolla; M Saginati; A Leprini; G Casari; F Baralle; L Zardi
Journal:  Nucleic Acids Res       Date:  1991-02-11       Impact factor: 16.971

9.  Measurement of protein using bicinchoninic acid.

Authors:  P K Smith; R I Krohn; G T Hermanson; A K Mallia; F H Gartner; M D Provenzano; E K Fujimoto; N M Goeke; B J Olson; D C Klenk
Journal:  Anal Biochem       Date:  1985-10       Impact factor: 3.365

10.  Human carcinoma cells synthesize and secrete tenascin in vitro.

Authors:  H Kawakatsu; R Shiurba; M Obara; H Hiraiwa; M Kusakabe; T Sakakura
Journal:  Jpn J Cancer Res       Date:  1992-10
View more
  8 in total

1.  Tenascin immunoreactivity in the large bowel and the liver in patients with colorectal cancer.

Authors:  M V Gulubova; T Vlaykova
Journal:  Histochem J       Date:  2001-02

2.  Laminins, tenascin and type VII collagen in colorectal mucosa.

Authors:  J Lohi; I Leivo; T Tani; T Kiviluoto; E Kivilaakso; R E Burgeson; I Virtanen
Journal:  Histochem J       Date:  1996-06

3.  Tenascin expression in inflammatory, dysplastic and neoplastic lesions of the human stomach.

Authors:  O Tiitta; P Sipponen; V Gould; I Virtanen
Journal:  Virchows Arch       Date:  1994       Impact factor: 4.064

4.  Stromal tenascin distribution as a prognostic marker in colorectal cancer.

Authors:  U Kressner; G Lindmark; B Tomasini-Johansson; R Bergström; B Gerdin; L Påhlman; B Glimelius
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

5.  The Promoting Effect of the Extracellular Matrix Peptide TNIIIA2 Derived from Tenascin-C in Colon Cancer Cell Infiltration.

Authors:  Hideo Suzuki; Manabu Sasada; Sadahiro Kamiya; Yuka Ito; Hikaru Watanabe; Yuko Okada; Kazuma Ishibashi; Takuya Iyoda; Akinori Yanaka; Fumio Fukai
Journal:  Int J Mol Sci       Date:  2017-01-17       Impact factor: 5.923

Review 6.  The Functional Role of Extracellular Matrix Proteins in Cancer.

Authors:  Nadezhda V Popova; Manfred Jücker
Journal:  Cancers (Basel)       Date:  2022-01-04       Impact factor: 6.639

7.  Immunohistochemical expression of tenascin in normal stomach tissue, gastric carcinomas and gastric carcinoma in lymph nodes.

Authors:  Y Ikeda; M Mori; K Kajiyama; Y Haraguchi; O Sasaki; K Sugimachi
Journal:  Br J Cancer       Date:  1995-07       Impact factor: 7.640

Review 8.  Tenascin-C: Form versus function.

Authors:  Sean P Giblin; Kim S Midwood
Journal:  Cell Adh Migr       Date:  2015       Impact factor: 3.405

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.